| Dr. Steve J.P. Hsu | |
| Chairman and CEO | |
| ● | Over 35 years in Pharma Industry |
| ● | Founder of Savior Lifetec Corporation |
| ● | VP of RD, ScinoPharm Taiwan |
| ● | Head of Pharma Division, Sinon Corporation |
| ● | Sr. Engineer of Merck & Co., Inc. |
| ● | Ph.D. ChE, Massachusetts Institute of Technology, USA |
| Kai-Der Ko | |
| CSO and Vice President | |
| ● | Over 30 years in Hi-Tech & Biotech Industry |
| ● | CEO, Champion Venture Capital Co., Ltd. |
| ● | Director of long-term investment, China Life Insurance Co., Ltd. |
| ● | AVP, Koos Group Venture capital Co. Ltd. |
| ● | Manager, China Investment & Development Co., Ltd. |
| ● | Researcher, Taiwan Biotech Co., Ltd. |
| ● | Executive Master of Business Administration, National Chengchi University |
| ● | Master of Science in Pharmacy, College of Medicine, National Taiwan University |
| Wen-Hsien Chen | |
| Vice President, Quality Center | |
| ● | Over 28 years in Pharmaceutical Industry |
| ● | Quality Director/Manager of QA at Savior Lifetec Co. Focus on QMS of a Sterile API and Injection Plant |
| ● | Rich experience in MAA and MAH inspections, such as US (FDA), Taiwan (TFDA), EU UK (MHRA), French (Afssaps), Spain (AEMPSM), Japan (PMDA), Korea (KFDA), Brazil (ANVISA), etc. |
| ● | QA Senior Specialist, ScinoPharm Taiwan, Ltd., focus on QMS and product development project, manufacturing scale-up, troubleshooting, etc. |
| ● | Master degree of Chemical Engineering from the Cleveland State University in Ohio, USA |
| ● | Bachelor of Science in Chemical Engineering from the National Taiwan University/ NTU in Taiwan. |
| Dr. Steve, Chih-Chiang Yang | |
| Chief Operating Officer, Tainan Site | |
| ● | Pharmaceutical and biotechnical product development experience over 23 years |
| ● | Develop drug product to launch on market over 20 items |
| ● | Professional skill in preparation of solid dosage form and injection delivery system, controlled release delivery system, pharmaceutical nanotechnology and lyophilization |
| ● | Well-experience in development of difficult generic product and special dosage form, 505(b)2 new formulation, and FIH formulation for NCE |
| ● | Worked as Director of pharmaceutical development department in Pharmaceutical and Medical Technology and Development Center, MOEATeach “Pharmaceutical Technology” course in School of Pharmacy, National Taiwan University |
| ● | Teach “Pharmaceutical Technology” course in School of Pharmacy, National Taiwan University |
| ● | PhD from Center for Drug Delivery Research, The School of Pharmacy, University of London, UK |
| ● | MSc from Graduated Institute of Pharmaceutical Science, National Taiwan University, Taiwan (Major in Pharmaceutics) |
| ● | Bachelor from School of Pharmacy, National Taiwan University, Taiwan |
| Gary Wong | |
| Senior Director, Quality Center | |
| ● | Over 29 years in Pharma/Biotech Industry |
| ● | Focus on science-based Risk Management System (RMS) and Quality Management System (QMS) based on Pharmaceutical Life Cycle Management (LCM) |
| ● | Rich experience in MAA and MAH inspections, such as Taiwan FDA, US FDA, EU QP (Germany, UK...etc.), KFDA, PMDA, France IPSEN, US Thermo Fisher, Canada Baxter,SQA,UniLab,etc. |
| ● | Quality Management Director, Centapharm Healthcare Group |
| ● | QA/RA Manager, Maxigen Biotech Inc. |
| ● | QA/VA Manager, Union Chem&Pharm Inc. |
| ● | Master and Bachelor degree of Chemical Engineering from the National Taiwan Institute of Technology/ NTIT (National Taiwan University of Science and Technology), Taiwan |
| Dr. On Lee | |
| Chief R&D Officer, RD Centert | |
| ● | Over 25 years in pharmaceuticals, fine chemicals, chemical processes |
| ● | PM of over 10 new chemical entities/30 processes development |
| ● | Well-experience in new drug R&D, organic synthesis, fine chemicals, analytical chemistry |
| ● | CRDO and Vice President, TaiwanJ Pharmaceuticals |
| ● | Principle Researcher, Industrial Technology Research Institute |
| ● | Ph.D. Medicinal Chemistry, Graduate School of Pharmacy, National Taiwan University |
| ● | Bachelor, Department of Pharmacy, National Taiwan University |
| Anderson Fan | |
| Senior Director, Sales Department | |
| ● | Master of Pharmacy, National Taiwan University |
| ● | Bachelor of China Medical University |
| ● | Business Development of injection Department, Formosa Laboratories, Inc. |
| ● | BD Manager of Oncology Department, TTY Biopharm Company Limited |
| ● | DMPK Researcher at TaiGen Biotechnology |
| Johnny Lo | |
| Senior Director, Bio Plant Department | |
| ● | Has more than 23 years of rich experiences in leading biopharmaceuticals development and GMP manufacturing |
| ● | Good at implementation of Quality-by-design concept into bioprocess development, improvement, intensification and scale-up, then GMP process validation and commercialized manufacturing. |
| ● | United BioPharma Quality Management Center VP |
| ● | United BioPharma Manufacturing Director |
| ● | UBIA Process Development and GMP manufacturing manager |
| ● | National Chung Cheng University Chemical Engineering Master |
| ● | Tunghai University Chemical Engineering Bechelor |
| Dr. Toby Fan | |
| Director, Head of Project Operations Department | |
| ● | Over 17 years of relevant experience in the biotechnology/pharmaceutical industry |
| ● | Focus on CDMO/CMO business currently |
| ● | Previous experience includes the development of the analytical methods, Controlled-/Targeted- drug & gene delivery systems, and lyophilized processes |
| ● | Manager, Project management department. Genovior Biotech Corporation |
| ● | Associate scientist, Formulation R&D Center, TTY Biopharm |
| ● | Postdoctoral Researcher, College of Life Science, National Taiwan University |
| ● | Ph.D., Chemistry from National Tsing Hua University |
| ● | M.S., Applied Chemistry from National Chi Nan University |
| Dr. Yu-Sheng Liu | |
| Director and Executive pharmacist, Head of Formulation Department | |
| ● | Over 14 years of relevant experience in the biotechnology/pharmaceutical industry |
| ● | Focus on the development of pre-formulation, formulation, lyophilized process for scale up, controlled-/targeted- drug delivery systems for pharmaceutical products |
| ● | Manager, Formulation department (R&D in Formulation), Genovior Biotech Corporation |
| ● | Executive pharmacist, Genovior Biotech Corporation |
| ● | Team leader, Formulation Research Lab of Pharmaceutical R&D Center, China Chemical& Pharmaceutical CO., LTD. |
| ● | Resident pharmacist, China Chemical& Pharmaceutical CO., LTD. |
| ● | Instructor, Environment and Life Sciences, Fooyin University |
| ● | Ph.D., Pharmacy from Kaohsiung Medical University |